Table 3. Biological activities of inhibitors guided by overlaying crystal structures.
![]() | |||||||||
Compd no. | R2 | R3 | clog P a | PfNMT K i (μM) | LipE b | HsNMT K i (μM) | S.I. c | EC50 d (μM) | LD50 e (μM) |
19 |
![]() |
H | 2.79 | 0.027 | 4.78 | 0.27 | 10 | 3.5 | 70 |
25 |
![]() |
H | 1.69 | 0.028 | 5.86 | 0.20 | 7 | 3.7 | >100 |
26 |
![]() |
Me | 2.09 | 0.57 | 4.15 | 0.51 | 0.9 | >30 | n.d. f |
27 |
![]() |
Et | 2.44 | 0.34 | 4.03 | 0.27 | 0.8 | >10 | n.d. |
28 |
![]() |
i-Pr | 2.85 | 0.090 | 4.20 | 0.18 | 2 | 3.2 | >100 |
30 |
![]() |
H | 3.14 | 0.0017 | 5.63 | 0.024 | 14 | 0.21 | 65 |
aclog P values calculated using ChemAxon software.
bLipE = pK i (PfNMT) – clog P.
cS.I., calculated as K i(HsNMT1)/K i(PfNMT).
d P. falciparum, 3D7 line was used.
eHepG2 cell line was used.
fn.d. = not determined.